Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.
Herpes simplex virus type 1 (HSV-1) thymidine kinase is currently used as a suicide agent in the gene therapy of cancer. This therapy is based on the preferential phosphorylation of nucleoside analogs by tumor cells expressing HSV-1 thymidine kinase. However, the use of HSV-1 thymidine kinase is lim...
Zapisane w:
| Wydane w: | Proc Natl Acad Sci U S A |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
National Academy of Sciences
1996
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC39643/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8622970/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.8.3525 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|